Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer.

We performed an experimental study on slow releasing anticancer drug implantation treatment as a new therapy for hepatocellular carcinoma. Hydroxyapatite (HAP) was chosen for the carrier material and doxorubicin hydrochloride (DOX) for anticancer agent. DOX-HAP was produced by adsorbing DOX to porou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunieda, K., Seki, T., Nakatani, S., Wakabayashi, M., Shiro, T., Inoue, K., Sougawa, M., Kimura, R., Harada, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968362/
https://www.ncbi.nlm.nih.gov/pubmed/8471423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968362/
https://www.ncbi.nlm.nih.gov/pubmed/8471423

Ejemplares similares